课题基金 / 基金详情

Homeostasis of Langerhans and Dendritic Cells in Health and Disease

Homeostasis of Langerhans and Dendritic Cells in Health and Disease
朗格汉斯和树突状细胞在健康和疾病中的稳态
批准号:
G0800358/1
负责人:
Venetia Bigley
金额:
$18.41万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2009
资助国家:
英国
项目状态:
已结题
起止时间:
2009 至 --

项目摘要

项目成果

Venetia Bigley的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Dendritic cells are critical components of the immune system. They detect foreign material and coordinate the immune response. Without them immunity to viruses, tumours and vaccines is severely compromised. They are important in the rejection of transplanted organs and in ‘graft versus host disease‘, a complication of bone marrow transplantation. Additionally, they multiply and accumulate in ‘histiocytosis‘, a rare but potentially fatal disease.The question we are studying is how these cells are maintained in the body. Previously they were thought to be replaced at a steady rate by cells from the blood. Recent evidence from mice suggests that they can proliferate or renew themselves but this is not known in humans. We propose to find out 1) whether human skin dendritic cells can renew themselves; 2) what controls their survival and proliferation; 3) whether they are affected by bone marrow failure. We will use normal human skin obtained from plastic surgery and small samples from patients with specific bone marrow disorders. Our experiments will help to understand how the immune system is controlled in health and disease, including bone marrow failure and transplantation. We may identify new ways to boost vaccination, prevent harmful immune responses and treat histiocytosis
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dynamic regulation of human immunity by Interferon Regulatory Factor 8 (IRF8)
  • 批准号:
    MR/W01677X/1
  • 项目类别:
    Fellowship
  • 资助金额:
    $273.72万
  • 财政年份:
    2022
  • 负责人:
    Venetia Bigley
  • 依托单位:
国内基金
海外基金
色氨酸代谢酶IL4I1参与活化迁移Langerhans细胞亚群负向调控特应性皮炎的作用及机制研究
温热通过TRPM2调控角质形成细胞NLRP3诱导Langerhans细胞成熟治疗疣机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2022
  • 负责人:
    郭昊
  • 依托单位:
调节性Langerhans细胞新亚群通过色氨酸代谢负向调控特应性皮炎的作用及机制研究
调节性Langerhans细胞新亚群通过色氨酸代谢负向调控特应性皮炎的作用及机制研究